scanance.
Sign inGet Premium
MD

Pediatrix Medical Group, Inc.

MDHealthcareNASDAQ

Medical Care Facilities · Last scanned Jun 2, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.91B
-4.9% YoY
Net Income
$165.4M
+266.9% YoY
EBITDA
$274.2M
+1066.5% YoY
Free Cash Flow
$163.7M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The $1.78B market capitalization puts MD squarely in small-cap range for its industry. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors.

Key stats
Market Cap$1.78B
P/E (TTM)10.50
Fwd P/E9.16
EPS$2.06
Beta0.71
52W Change+56.7%
ROE20.9%
Analysis

On the balance sheet, MD has $329.0M in cash with $629.7M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $163.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 20.9% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.97B (2022) to $1.91B (2025).

As with any equity investment, MD carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Pediatrix Medical Group, Inc. and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms